Health Press Release – Newsletter for May 20, 2010
Thursday, May 20, 2010
Reach the core of sexuality with Kamagra Jelly
Kamagra jelly has been the genuine form of Generic Viagra. It is the best online form of medication that works in dealing with male impotence. Erectile dysfunction (ED) or impotence is a male sexual syndrome that affects the quality of sex life. It is the inability of the sexually aroused man to attain a penile [...]
Ghana Pharmaceuticals and Healthcare Report Q2 2010
Dallas, TX: ReportsandReports announce it will carry Ghana Pharmaceuticals and Healthcare Report Q2 2010 Market Research Report in its Store.
BMI’s new Ghana pharmaceuticals and healthcare report includes top-line pharmaceutical market and healthcare spending data through to 2019, including our views on growth drivers in this sector. Pharmaceutical spending in Ghana is expected to rise at [...]
Remote & Wireless Patient Monitoring Markets
Dallas, TX: ReportsandReports announce it will carry Remote & Wireless Patient Monitoring Markets Market Research Report in its Store.
Patient monitoring systems are emerging in response to increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness.
Of these new [...]
M&As on the Rise in the European Medical Imaging Market as Market Leaders Focus on Expanding their Share in Emerging Markets, Says Frost & Sullivan
LONDON, May 19, 2010 – There has been an increasing number of mergers and acquisitions (M&As) in
the European medical imaging market with market leaders focussing on
acquisitions to expand their share in emerging markets. Drug makers, research
labs, equipment manufacturers and healthcare technology companies have been
the active acquirers, whereas hospitals, insurers and pharmacological
companies have a limited [...]
Shire Receives 2010 Corporate Award From the National Organization for Rare Disorders (NORD) for the Development of VPRIV (velaglucerase alfa for Injection)
Organization Recognizes Shire's Commitment to the Gaucher Disease Community
CAMBRIDGE, Massachusetts, May 19, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that it has received the 2010
Partners in Progress Corporate Award from NORD. Shire was recognized for its
efforts to accelerate the development of VPRIV(TM), a human cell line derived
enzyme [...]
Essilor Sells its Stake in Sperian Protection
CHARENTON-LE-PONT, France, May 19, 2010 – Sperian Protection's Board of Directors agreed this morning to
accept Honeywell's voluntary tender offer to acquire 100% of its capital at a
price of EUR117 per share.
Essilor has agreed to sell all of its Sperian Protection
shares to Honeywell in an off-market transaction, based on the offering [...]
AMT Provides Business Update for the First Quarter 2010
AMSTERDAM, May 19, 2010 – Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in
the field of human gene therapy, today provides its non-audited business
update in compliance with the EU transparency directive. This report
summarizes material events and AMT's financial position for the first quarter
of 2010.
Q1 2010 Highlights
– [...]
The French Competition Authority Follows up Allegations of Anti-competitive Practices by Sanofi-Aventis to Exclude Fair Generic Competition for Plavix(R) (clopidogrel)
UTRECHT, The Netherlands, May 19, 2010 – Teva Sant??, one of France's leading generic medicines
companies, has welcomed news that the French Competition Authority has agreed
to its request to investigate alleged anti-competitive practices by
Sanofi-Aventis aimed at preventing generic competition to its Plavix(R)
(clopidogrel) treatment.
In November last year, Teva Sant?? filed a complaint [...]